Minimal residual disease-based effect and long-term outcome of first-line dasatinib combined with chemotherapy for adult Philadelphia chromosome-positive acute lymphoblastic leukemia

Autor: Yoon, J.-H., Yhim, H.-Y., Kwak, J.-Y., Ahn, J.-S., Yang, D.-H., Lee, J.-J., Kim, S.-J., Kim, J.-S., Park, S.J., Choi, C.W., Eom, H.-S., Park, S.-K., Choi, S.-Y., Kim, S.-H., Kim, D.-W., Lee, S. *
Zdroj: In Annals of Oncology June 2016 27(6):1081-1088
Databáze: ScienceDirect